Gamma-cyclodextrin as molecular chaperone in protein delivery and stabilization
The interaction of a small, monomeric cytoplasmic protein, Cellular retinoic acid binding protein I (CRABPI), with cyclodextrins (α-, β-, and
Category: Drug delivery
Launch of KLEPTOSE® Crysmeb Methyl-Beta-Cyclodextrin for Oral and Parenteral Formulations
Roquette {oosts Extensive Cyclodextrins Portfolio with Launch of KLEPTOSE® Crysmeb Methyl-Beta-Cyclodextrin for Oral and Parenteral Formulations In contrast to DIMEB
Supramolecular Nanomedicine for Cancer: Research, Collaboration, and Dialogue – First Online Workshop of the NextNano4Cancer project
This workshop is part of the NextNano4Cancer project, funded under the ERA4Health Joint Transnational Call “Nano and advanced technologies for
Eco-Hydrogels: The Next Big Step Toward Sustainable Materials
In the quest for greener materials, scientists are turning their attention to an unlikely hero — hydrogels, those soft, water-filled
SQ Innovation: FDA Approval for Lasix® ONYU, an At-Home Treatment for Edema in Heart Failure Patients
This second-generation delivery device provides a cost-efficient alternative to in-hospital treatment. Lasix® ONYU represents the most recent FDA-approved formulation incorporating
Nobel prize in chemistry in regard of cyclodextrin chemistry and application
Chemists Susumu Kitagawa, Richard Robson and Omar Yaghi won the 2025 Nobel Prize in Chemistry for developing the world’s most
Recently published studies on dimethyl beta-CD
All these studies utilize the high solubilizing effect of 2,6-di-O-methyl beta-cyclodextrin studying various model drugs. The compatibility, inclusion stability, and
Beta cyclodextrin stabilized cupric oxide nanoparticles assisted thermal therapy for lung tumor and its effective in vitro anticancer activity
The unique physicochemical properties of cupric oxide nanoparticles (CuO NPs) make them suitable for a wide range of therapeutic applications.
Cyclodextrin-based formulations for pediatric patients: pharmaceutical prospectives and toxicological evaluation
Pediatric drug development faces notable challenges due to age-related physiological differences, with limited approved formulations often leading to off-label or
Enhanced solubility, stability, and bioavailability of astilbin via inclusion complexes formation with methyl-β-cyclodextrin
This article investigates the complexation of astilbin (Ast), a poorly soluble flavonoid, with methyl-β-cyclodextrin (M-β-CD) to enhance its solubility, stability,